BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25268855)

  • 1. Central lymph node characteristics predictive of outcome in patients with differentiated thyroid cancer.
    Wang LY; Palmer FL; Nixon IJ; Thomas D; Shah JP; Patel SG; Tuttle RM; Shaha AR; Ganly I
    Thyroid; 2014 Dec; 24(12):1790-5. PubMed ID: 25268855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.
    Wang LY; Palmer FL; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I
    Ann Surg Oncol; 2015 Oct; 22(11):3530-6. PubMed ID: 25665952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement.
    Liu Z; Fang Z; Dai T; Zhang C; Sun J; He Y
    J Craniomaxillofac Surg; 2015 Jul; 43(6):751-7. PubMed ID: 25958766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
    Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
    Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.
    Ryu IS; Song CI; Choi SH; Roh JL; Nam SY; Kim SY
    Ann Surg Oncol; 2014 Jan; 21(1):277-83. PubMed ID: 24006096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma.
    Moritani S
    Thyroid; 2014 Dec; 24(12):1779-83. PubMed ID: 25157399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
    Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia.
    Cho SY; Lee TH; Ku YH; Kim HI; Lee GH; Kim MJ
    Surgery; 2015 Jan; 157(1):111-8. PubMed ID: 25444224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
    Passoni NM; Fajkovic H; Xylinas E; Kluth L; Seitz C; Robinson BD; RouprĂȘt M; Chun FK; Lotan Y; Roehrborn CG; Crivelli JJ; Karakiewicz PI; Scherr DS; Rink M; Graefen M; Schramek P; Briganti A; Montorsi F; Tewari A; Shariat SF
    BJU Int; 2014 Oct; 114(4):503-10. PubMed ID: 24053552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma.
    Koo BS; Yoon YH; Kim JM; Choi EC; Lim YC
    Ann Surg Oncol; 2009 May; 16(5):1344-7. PubMed ID: 19224280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer.
    Jeon MJ; Kim YN; Sung TY; Hong SJ; Cho YY; Kim TY; Shong YK; Kim WB; Kim SW; Chung JH; Kim TH; Kim WG
    Thyroid; 2018 Feb; 28(2):193-200. PubMed ID: 29179646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
    Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.
    Wang LY; Palmer FL; Nixon IJ; Thomas D; Patel SG; Shaha AR; Shah JP; Tuttle RM; Ganly I
    Thyroid; 2014 Nov; 24(11):1594-9. PubMed ID: 25162180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma.
    Lee SH; Lee SS; Jin SM; Kim JH; Rho YS
    Laryngoscope; 2008 Apr; 118(4):659-62. PubMed ID: 18176339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level 7 disease does not confer worse outcome than level 6 disease in differentiated thyroid cancer.
    Wang LY; Palmer FL; Thomas D; Nixon IJ; Tuttle RM; Shah JP; Patel SG; Shaha AR; Ganly I
    Ann Surg Oncol; 2015 Feb; 22(2):441-5. PubMed ID: 25190124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.